Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Tomato Lycopene May Affect the IGF-System, Reduce Cancer Risk - Nutraceuticals World
Research

Tomato Lycopene May Affect the IGF-System, Reduce Cancer Risk

Results of a study published in the November 2007 American Journal of Clinical Nutrition suggest that supplementing the diet with tomato lycopene may decrease cancer risk by interfering with the insulin-like growth factor (IGF) system.

The 8-week, double-blind study, funded by the Dutch Cancer Society, investigated the effect of supplementation with 30 mg per day of tomato lycopene on serum concentrations of IGF-I and -II, which are associated with increased prostate, premenopausal breast, and colorectal cancer risk, and on their binding proteins (IGFBP-1, -2, and -3). In this trial, 76 men and women at greater risk of colorectal cancer participated, using tomato lycopene capsules supplied by LycoRed.

“This is the first study known to show that lycopene supplementation may increase circulating IGFBP-1 and IGFBP-2 concentrations, thereby potentially decreasing IGF-I bioavailability,” said researcher Alina Vrieling of the Netherlands Cancer Institute in Amsterdam. “Thus, it may provide a means of ultimately reducing colorectal cancer risk, and potentially the risks of other major cancers such as prostate and premenopausal breast cancer.”

For further information: 972-8-6296-630.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters